FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2574014792> ?p ?o ?g. }

• W2574014792 endingPage "90" @default.
• W2574014792 startingPage "79" @default.
• W2574014792 abstract "This study evaluates outcomes in chronic lymphocytic leukemia (CLL) based on first-line therapy in a large consecutive population-based cohort of 669 patients with fluorescence in-situ hybridization (FISH) data in British Columbia, Canada during the period when chemoimmunotherapy was standard first-line treatment. When analyzed as a time-dependent variable, patients who required treatment (n = 336) had a 4.7 times higher hazard of death than patients who did not (95% confidence interval 2.8–7.9, P < 0.001). The majority of patients received fludarabine-rituximab (FR) in front-line. On multivariate Cox regression analysis, fludarabine-based first-line therapy predicted longer time-to-next-treatment (TTNT) (HR 0.53, 95% confidence interval 0.33–0.87, P = 0.012) but no difference in overall survival (OS) compared to alkylator-based therapy. Deletion 17p was an independent predictor of worse TTNT and OS. The most common second-line treatments were cyclophosphamide-vincristine-prednisone-rituximab and FR. There was no difference in OS between patients retreated in second-line with the same first-line regimen (n = 33) versus different regimen (n = 113). In conclusion, front-line treatment with fludarabine leads to a longer time until need for next treatment than alkylator-based therapy; however, fludarabine or alkylator therapy produces no difference in OS. This study provides a historical baseline for the comparison of novel agents with standard treatments in CLL on a population-level." @default.
• W2574014792 created "2017-01-26" @default.
• W2574014792 creator A5002242533 @default.
• W2574014792 creator A5006888644 @default.
• W2574014792 creator A5013413062 @default.
• W2574014792 creator A5020565431 @default.
• W2574014792 creator A5025101341 @default.
• W2574014792 creator A5031948436 @default.
• W2574014792 creator A5034771074 @default.
• W2574014792 creator A5059894379 @default.
• W2574014792 creator A5071701043 @default.
• W2574014792 creator A5082635085 @default.
• W2574014792 creator A5083812935 @default.
• W2574014792 date "2017-04-01" @default.
• W2574014792 modified "2023-10-06" @default.
• W2574014792 title "Characterization of treatment and outcomes in a population-based cohort of patients with chronic lymphocytic leukemia referred for cytogenetic testing in British Columbia, Canada" @default.
• W2574014792 cites W1243376384 @default.
• W2574014792 cites W154103547 @default.
• W2574014792 cites W1910740057 @default.
• W2574014792 cites W1970312642 @default.
• W2574014792 cites W1974855794 @default.
• W2574014792 cites W1975590576 @default.
• W2574014792 cites W1982422376 @default.
• W2574014792 cites W1988682601 @default.
• W2574014792 cites W1993986769 @default.
• W2574014792 cites W1998208839 @default.
• W2574014792 cites W2032159505 @default.
• W2574014792 cites W2047835302 @default.
• W2574014792 cites W2054577656 @default.
• W2574014792 cites W2054709506 @default.
• W2574014792 cites W2063204645 @default.
• W2574014792 cites W2079188511 @default.
• W2574014792 cites W2096065464 @default.
• W2574014792 cites W2108726442 @default.
• W2574014792 cites W2111714917 @default.
• W2574014792 cites W2112937953 @default.
• W2574014792 cites W2139881349 @default.
• W2574014792 cites W2140606816 @default.
• W2574014792 cites W2142099365 @default.
• W2574014792 cites W2149147062 @default.
• W2574014792 cites W2169038235 @default.
• W2574014792 cites W2275948481 @default.
• W2574014792 cites W2323490326 @default.
• W2574014792 cites W2326175431 @default.
• W2574014792 cites W2337485820 @default.
• W2574014792 cites W2537944738 @default.
• W2574014792 cites W2584875660 @default.
• W2574014792 cites W60865865 @default.
• W2574014792 doi "https://doi.org/10.1016/j.leukres.2017.01.023" @default.
• W2574014792 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28157628" @default.
• W2574014792 hasPublicationYear "2017" @default.
• W2574014792 type Work @default.
• W2574014792 sameAs 2574014792 @default.
• W2574014792 citedByCount "7" @default.
• W2574014792 countsByYear W25740147922018 @default.
• W2574014792 countsByYear W25740147922019 @default.
• W2574014792 countsByYear W25740147922020 @default.
• W2574014792 countsByYear W25740147922021 @default.
• W2574014792 countsByYear W25740147922023 @default.
• W2574014792 crossrefType "journal-article" @default.
• W2574014792 hasAuthorship W2574014792A5002242533 @default.
• W2574014792 hasAuthorship W2574014792A5006888644 @default.
• W2574014792 hasAuthorship W2574014792A5013413062 @default.
• W2574014792 hasAuthorship W2574014792A5020565431 @default.
• W2574014792 hasAuthorship W2574014792A5025101341 @default.
• W2574014792 hasAuthorship W2574014792A5031948436 @default.
• W2574014792 hasAuthorship W2574014792A5034771074 @default.
• W2574014792 hasAuthorship W2574014792A5059894379 @default.
• W2574014792 hasAuthorship W2574014792A5071701043 @default.
• W2574014792 hasAuthorship W2574014792A5082635085 @default.
• W2574014792 hasAuthorship W2574014792A5083812935 @default.
• W2574014792 hasConcept C126322002 @default.
• W2574014792 hasConcept C141071460 @default.
• W2574014792 hasConcept C143998085 @default.
• W2574014792 hasConcept C207103383 @default.
• W2574014792 hasConcept C2776694085 @default.
• W2574014792 hasConcept C2776755627 @default.
• W2574014792 hasConcept C2777938653 @default.
• W2574014792 hasConcept C2778461978 @default.
• W2574014792 hasConcept C2779015954 @default.
• W2574014792 hasConcept C2779263901 @default.
• W2574014792 hasConcept C2779338263 @default.
• W2574014792 hasConcept C2779429289 @default.
• W2574014792 hasConcept C2780653079 @default.
• W2574014792 hasConcept C2780790343 @default.
• W2574014792 hasConcept C2781413609 @default.
• W2574014792 hasConcept C2908647359 @default.
• W2574014792 hasConcept C2911091166 @default.
• W2574014792 hasConcept C44249647 @default.
• W2574014792 hasConcept C50382708 @default.
• W2574014792 hasConcept C71924100 @default.
• W2574014792 hasConcept C72563966 @default.
• W2574014792 hasConcept C99454951 @default.
• W2574014792 hasConceptScore W2574014792C126322002 @default.
• W2574014792 hasConceptScore W2574014792C141071460 @default.
• W2574014792 hasConceptScore W2574014792C143998085 @default.
• W2574014792 hasConceptScore W2574014792C207103383 @default.
• W2574014792 hasConceptScore W2574014792C2776694085 @default.

• next